JP2004534831A5 - - Google Patents

Download PDF

Info

Publication number
JP2004534831A5
JP2004534831A5 JP2003507262A JP2003507262A JP2004534831A5 JP 2004534831 A5 JP2004534831 A5 JP 2004534831A5 JP 2003507262 A JP2003507262 A JP 2003507262A JP 2003507262 A JP2003507262 A JP 2003507262A JP 2004534831 A5 JP2004534831 A5 JP 2004534831A5
Authority
JP
Japan
Prior art keywords
isomerase
chaperone
soluble
complex
retroviral surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003507262A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004534831A (ja
JP4262594B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/006956 external-priority patent/WO2003000877A2/en
Publication of JP2004534831A publication Critical patent/JP2004534831A/ja
Publication of JP2004534831A5 publication Critical patent/JP2004534831A5/ja
Application granted granted Critical
Publication of JP4262594B2 publication Critical patent/JP4262594B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003507262A 2001-06-22 2002-06-24 レトロウイルス表面糖タンパク質を含む可溶性複合体 Expired - Fee Related JP4262594B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01115225 2001-06-22
EP01120939 2001-08-31
PCT/EP2002/006956 WO2003000877A2 (en) 2001-06-22 2002-06-24 A soluble complex comprising a retroviral surface glycoprotein

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2007183508A Division JP4320351B2 (ja) 2001-06-22 2007-07-12 レトロウイルス表面糖タンパク質を含む可溶性複合体
JP2008286959A Division JP2009102320A (ja) 2001-06-22 2008-11-07 レトロウイルス表面糖タンパク質を含む可溶性複合体

Publications (3)

Publication Number Publication Date
JP2004534831A JP2004534831A (ja) 2004-11-18
JP2004534831A5 true JP2004534831A5 (https=) 2005-09-15
JP4262594B2 JP4262594B2 (ja) 2009-05-13

Family

ID=26076626

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2003507263A Expired - Fee Related JP4174422B2 (ja) 2001-06-22 2002-06-24 発現ツールとしてのｆｋｂｐシャペロンの使用
JP2003507262A Expired - Fee Related JP4262594B2 (ja) 2001-06-22 2002-06-24 レトロウイルス表面糖タンパク質を含む可溶性複合体
JP2006326846A Expired - Fee Related JP4309910B2 (ja) 2001-06-22 2006-12-04 発現ツールとしてのｆｋｂｐシャペロンの使用
JP2007183508A Expired - Fee Related JP4320351B2 (ja) 2001-06-22 2007-07-12 レトロウイルス表面糖タンパク質を含む可溶性複合体
JP2008286959A Withdrawn JP2009102320A (ja) 2001-06-22 2008-11-07 レトロウイルス表面糖タンパク質を含む可溶性複合体
JP2009025509A Expired - Fee Related JP4523660B2 (ja) 2001-06-22 2009-02-06 発現ツールとしてのｆｋｂｐシャペロンの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2003507263A Expired - Fee Related JP4174422B2 (ja) 2001-06-22 2002-06-24 発現ツールとしてのｆｋｂｐシャペロンの使用

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2006326846A Expired - Fee Related JP4309910B2 (ja) 2001-06-22 2006-12-04 発現ツールとしてのｆｋｂｐシャペロンの使用
JP2007183508A Expired - Fee Related JP4320351B2 (ja) 2001-06-22 2007-07-12 レトロウイルス表面糖タンパク質を含む可溶性複合体
JP2008286959A Withdrawn JP2009102320A (ja) 2001-06-22 2008-11-07 レトロウイルス表面糖タンパク質を含む可溶性複合体
JP2009025509A Expired - Fee Related JP4523660B2 (ja) 2001-06-22 2009-02-06 発現ツールとしてのｆｋｂｐシャペロンの使用

Country Status (15)

Country Link
US (2) US7244819B2 (https=)
EP (3) EP1402015B1 (https=)
JP (6) JP4174422B2 (https=)
KR (2) KR100702373B1 (https=)
CN (1) CN100510068C (https=)
AT (2) ATE445016T1 (https=)
AU (2) AU2002317841A1 (https=)
BR (1) BRPI0210598B8 (https=)
CA (3) CA2449747C (https=)
DE (1) DE60233942D1 (https=)
DK (2) DK1402015T3 (https=)
ES (3) ES2391623T3 (https=)
MX (1) MXPA03011455A (https=)
PL (2) PL218245B1 (https=)
WO (2) WO2003000878A2 (https=)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1402015T3 (da) * 2001-06-22 2011-12-05 Hoffmann La Roche Opløseligt kompleks omfattende et retroviralt overfladeglycoprotein og FkpA eller SlyD
CA2490384A1 (en) * 2002-06-25 2003-12-31 Sekisui Chemical Co., Ltd. Expression vector, host, fused protein, process for producing fused protein and process for producing protein
WO2004047869A1 (en) * 2002-11-26 2004-06-10 Danmarks Fødevareforskning Dendrimer conjugates for selective of protein aggregates
WO2004092221A1 (ja) * 2003-04-18 2004-10-28 Sekisui Chemical Co. Ltd. 免疫原及び免疫用組成物、並びにそれらを使用する抗体の製造方法
DK2330200T3 (en) * 2004-12-23 2017-07-24 Albumedix As GENE EXPRESSION TECHNIQUE
CA2562738C (en) 2005-10-26 2011-07-12 F. Hoffmann-La Roche Ag Soluble rubella e1 envelope antigens
CA2636075C (en) * 2006-01-03 2011-11-08 F. Hoffmann-La Roche Ag Chimaeric fusion protein with superior chaperone and folding activities
WO2007141650A2 (en) * 2006-01-17 2007-12-13 Instituto De Medicina Molecular Compositions and methods for diagnosing hiv-2 infection
US8962262B2 (en) 2006-05-11 2015-02-24 Arbor Vita Corporation Method of protein extraction from cells
GB0611405D0 (en) 2006-06-09 2006-07-19 Univ Belfast FKBP-L: A novel inhibitor of angiogenesis
PL2112158T3 (pl) 2007-04-20 2012-03-30 Hoffmann La Roche Wykrywanie pierwotnych infekcji wywołanych patogenami
US20100210827A1 (en) * 2007-09-06 2010-08-19 Nutrex Technology Co., Ltd. Preparation Method Of Recombinant Protein By Use Of A Fusion Expression Partner
US9207240B2 (en) 2007-11-14 2015-12-08 Arbor Vita Corporation Method of efficient extraction of protein from cells
EP2222694B1 (en) 2007-12-13 2014-01-15 Roche Diagnostics GmbH Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies
EP2127678A1 (en) 2008-05-26 2009-12-02 Roche Diagnostics GmbH SlpA as a tool for recombinant protein and enzyme technology
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
EP2670847B1 (en) * 2011-02-03 2016-10-05 XOMA Technology Ltd. Methods and materials for enhancing functional protein expression in bacteria
AR086250A1 (es) * 2011-05-05 2013-11-27 Hoffmann La Roche Polipeptido de fusion presentador de una secuencia de aminoacidos y utilizacion del mismo
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2617731A1 (en) 2012-01-19 2013-07-24 Roche Diagnostics GmbH Soluble immunoreactive Treponema pallidum TpN47 antigens
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
EP2706115A1 (en) 2012-09-06 2014-03-12 Roche Diagnostics GmbH Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays
MX2015005757A (es) 2012-11-08 2015-11-18 Hoffmann La Roche Proteinas ligantes de antigeno her3 de union a la horquilla beta de her3.
US12540318B2 (en) * 2012-11-08 2026-02-03 Roche Diagnostics Operations, Inc. Nucleic acids encoding chimeric polypeptides for library screening
US9725511B2 (en) 2012-11-08 2017-08-08 Hoffmann-La Roche Inc. Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4
EP2827146A1 (en) 2013-07-18 2015-01-21 Roche Diagnostics GmbH Vibrio cholerae lipoprotein 15 (Lp15) variants as anti-interference additive in TpN17-based immunoassays for detection of anti-Treponema antibodies
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
EP3049437A1 (en) * 2013-09-27 2016-08-03 F. Hoffmann-La Roche AG Thermus thermophilus slyd fkbp domain specific antibodies
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP2913338A1 (en) 2014-02-28 2015-09-02 Roche Diagniostics GmbH Soluable and immunoreactive variants of HTLV capsid antigen p24
JP2015215244A (ja) * 2014-05-12 2015-12-03 富士レビオ株式会社 免疫測定における抗ｈｔｌｖ抗体の検出感度を向上させる方法
MX2016014416A (es) 2014-05-14 2017-02-23 Hoffmann La Roche Anticuerpos anti-her3 que se unen a la horquilla beta de her3.
MX2016014862A (es) * 2014-05-14 2017-02-27 Hoffmann La Roche Her3 / her2 anticuerpos biespecificos que se unen a la horquilla beta de her3 y al dominio ii de her2.
JP6817939B2 (ja) * 2014-12-01 2021-01-20 フェネックス インク． ペプチド産生のための融合パートナー
US20180023098A1 (en) * 2015-02-13 2018-01-25 Sekisui Chemical Co., Ltd. Nucleic acid, fusion protein, recombined cell, and isoprene or cyclic terpene production method
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
KR102943992B1 (ko) * 2015-12-15 2026-03-25 에프. 호프만-라 로슈 아게 트랜스글루타미나제 인식 부위를 갖는 fkbp 도메인
JP7044721B2 (ja) 2016-05-31 2022-03-30 エフ．ホフマン－ラ ロシュ アーゲー Ｈｃｖコア抗原の迅速な検出のための前処理法
EP3465217B1 (en) 2016-05-31 2025-09-03 Roche Diagnostics GmbH Method for serological detection of viral antigens
EP3472322B1 (en) * 2016-06-20 2022-01-05 MetGen Oy Method for obtaining active insoluble xylose isomerase
WO2018141768A1 (en) 2017-02-02 2018-08-09 Roche Diagnostics Gmbh Immunoassay using at least two pegylated analyte-specific binding agents
BR112019022384A2 (pt) 2017-04-26 2020-05-26 F. Hoffmann-La Roche Ag Polipeptídeo apropriado para detecção de anticorpos contra vírus zika, métodos de produção de polipeptídeo, de detecção de anticorpos específicos para vírus zika e de detecção de anticorpos contra vírus zika, uso de polipeptídeo do vírus zika e kit de reagentes
ES2961462T3 (es) 2017-07-27 2024-03-12 Roche Diagnostics Gmbh Proteína de fusión multiepítopo de un antígeno del VHC y usos de la misma
CN110066343B (zh) * 2019-05-23 2021-04-09 北京新创生物工程有限公司 一种用于检测hiv新发感染的重组抗原及其应用
CN115843334B (zh) 2020-04-23 2026-01-13 豪夫迈·罗氏有限公司 用于抗体免疫测定的冠状核衣壳抗原
EP4380955A1 (en) 2021-08-06 2024-06-12 Roche Diagnostics GmbH Chimeric igg-fc-binding ligand polypeptide and uses thereof for igg affinity purification
WO2023213758A1 (en) 2022-05-03 2023-11-09 F. Hoffmann-La Roche Ag Hiv gp41 variants for immunodiagnostic assays
WO2025098623A1 (en) 2023-11-09 2025-05-15 Roche Diagnostics Gmbh Transglutaminase substrates for labeling

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2095818B (en) 1981-03-27 1985-10-02 Exxon Research Engineering Co Staged adsorption/resorption heat pump
US4735896A (en) 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
US4879212A (en) 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US5811128A (en) 1986-10-24 1998-09-22 Southern Research Institute Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
DE3705686C2 (de) 1987-02-23 1995-11-30 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Antikörpern
NZ224663A (en) 1987-05-28 1990-11-27 Amrad Corp Ltd Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors
SE8704185L (sv) 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
DE69223250T3 (de) 1991-06-14 2008-02-28 Idexx Laboratories, Inc. Detektion des immunschwäche-virus aus felis
JPH07504561A (ja) * 1991-12-20 1995-05-25 ノボ　ノルディスク　アクティーゼルスカブ リパーゼの製造のための方法
EP0644950A4 (en) 1992-04-09 1997-05-14 Abbott Lab ASSAY FOR THE DETECTION OF HIV ANTIGEN AND HIV ANTIBODIES.
AU4400593A (en) 1992-06-05 1994-01-04 Abbott Laboratories Methods and reagents for the determination of immunosuppressive agents
EP0663010B1 (en) 1992-10-02 2000-08-09 Research Corporation Technologies, Inc. Methods for increasing secretion of overexpressed proteins
US5459051A (en) 1993-03-26 1995-10-17 Celtrix Pharmaceuticals, Inc. Methods and vectors for over-expression of ubiquitin fusion proteins in host cells
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
JPH11511643A (ja) 1994-10-25 1999-10-12 ザ・ボード・オブ・トラスティーズ・オブ・ザ・リランド・スタンフォード・ジュニア・ユニバーシティ 遺伝子工学処理された細胞の条件的形質転換
KR19990022651A (ko) 1995-06-07 1999-03-25 데이비드 엘. 버스테인 생물학적 사건에 대한 라파마이신 기재 조절방법
EP0855029A4 (en) 1995-09-15 2000-03-08 Merck & Co Inc An assay with high throughput using fusion protein
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
GB9614114D0 (en) 1996-07-05 1996-09-04 Amcor Packaging Uk Ltd New packages
AU736670B2 (en) 1996-09-26 2001-08-02 Medical Research Council Chaperone fragments
US6225082B1 (en) 1997-05-09 2001-05-01 Research Corporation Technologies, Inc. Myelin basic protein MRNA transport and translation enhancer sequences
US5989868A (en) * 1997-09-12 1999-11-23 The Board Of Regents Of The University Of Oklahoma Fusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in esherichia coli
CA2318402A1 (en) 1998-01-15 1999-07-22 Ariad Gene Therapeutics, Inc. Regulation of biological events using multimeric chimeric proteins
DE19913117A1 (de) * 1998-05-06 1999-11-11 Roche Diagnostics Gmbh Entstörung durch Rheumafaktoren
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
ATE473755T1 (de) * 1998-10-02 2010-07-15 Rhein Biotech Proz & Prod Gmbh Methode zur herstellung von (poly)peptiden unter verwendung von verkürzten varianten von sv40 large t antigen mit einem intakten n terminus
JP2002529081A (ja) 1998-11-06 2002-09-10 プレジデント アンド フェローズ オブ ハーバード カレッジ 生物学的事象のｆｋ５０６に基づく調節
EP1161440A1 (en) 1999-03-17 2001-12-12 Medical Research Council Method for refolding molecules of polypeptides containing ig domains
AU4933200A (en) 1999-05-14 2000-12-05 Medical Research Council Oligomeric chaperone proteins
GB9913437D0 (en) 1999-06-09 1999-08-11 Medical Res Council Fusion proteins
EP1077263A1 (de) * 1999-07-29 2001-02-21 F.Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen durch Co-Sekretion von Chaperonen
CA2403718A1 (en) 2000-03-17 2001-09-27 Panacos Pharmaceuticals, Inc. A method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of hiv envelope proteins
JP2002262883A (ja) * 2001-03-13 2002-09-17 Sekisui Chem Co Ltd モノクローナル抗体の製造方法
DK1402015T3 (da) * 2001-06-22 2011-12-05 Hoffmann La Roche Opløseligt kompleks omfattende et retroviralt overfladeglycoprotein og FkpA eller SlyD

Similar Documents

Publication Publication Date Title
JP2004534831A5 (https=)
CA2450476A1 (en) A soluble complex comprising a retroviral surface glycoprotein
EP2343318A3 (en) Antibodies binding to a C-terminal fragment of apolipoprotein E
HK1045259A1 (zh) 具改良药理动力性质之杂合多肽
WO2003070752A3 (en) Mhc-peptide complex binding ligands
CA2468583A1 (en) Self-assembling multimeric binding complexes derived from ab5 toxin family members
EP2360259A3 (en) Promyostatin peptides and methods of using same
WO2007047829A3 (en) Novel heterodimeric proteins and uses thereof
PL393286A1 (pl) Rozpuszczalny receptor BR43x2 i sposoby jego zastosowania
WO2002079232A3 (en) Reducing the immunogenicity of fusion proteins
WO2006081249A8 (en) Conjugates of biologically active proteins having a modified in vivo half-life
ATE533784T1 (de) Lösliche, einzelkettige proteine des t- zellrezeptors
WO2003033677A3 (en) Dimerized growth factor and materials and methods for producing it
JP2003517300A5 (https=)
DE60331677D1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
NO20002691L (no) IFNAR2/IFN kompleks
WO2009074318A3 (en) Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies
WO2007067596A3 (en) Methods and compositions for needleless delivery of antibodies
ATE366420T1 (de) Kit und verfahren zur bestimmung von protein esm- 1
WO2006101782A3 (en) A cysteine-containing peptide tag for site-specific conjugation of proteins
JPWO2023234416A5 (https=)
Wade et al. Use of thiazolidine-mediated ligation for site specific biotinylation of mouse EGF for biosensor immobilisation
WO2001016182A3 (en) POLYPEPTIDES THAT BIND HIV gp120 AND RELATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE
EP1326895B8 (fr) Anticorps monoclonaux diriges contre des virus de l'hepatite b
JP2003500341A5 (https=)